Industry Conference

Water Tower Research's upcoming conference isn't just another event; it's a blueprint for a market where C-suite access is no longer an exclusive club.

CEO Kelly Ortberg's upcoming speech is more than a financial update; it's a referendum on Boeing's ability to navigate global turbulence and deliver on its ambitious promises.

The 2nd Annual Glazier Expo unites industry leaders to showcase innovation, foster education, and combat Ontario's skilled trades gap. Here's why it matters.

A new partnership promises to untether live broadcasting with private 5G, offering a glimpse into a future with fewer cables, lower costs, and more creative freedom.

As Stoke prepares for a key investor conference, its lead drug zorevunersen nears a pivotal Phase 3 readout, promising a new era for patients and the RNA platform.

As Netcracker showcases its agentic AI in Düsseldorf, the telecom sector is at a crossroads. Is this the moment AI moves from a cost-saver to a core revenue driver?

As iBio heads to a key investor conference, its AI-driven antibody platform aims to solve the GLP-1 paradox: achieving sustainable weight loss by preserving muscle.

As specialty contractor MYR Group meets with top investors, its strategy reveals a bigger story: how firms building our green infrastructure are Wall Street's new darlings.

As Alamar Biosciences prepares for a key fireside chat at Morgan Stanley, all eyes are on its NULISA™ technology and its rapid commercial growth.

NAMA is seeking experts for its 2027 show, setting the stage for innovation in AI, micro markets, and unattended retail. Here's what it means.

As the UN spotlights global rangelands, a new report shows Canadian beef farmers are key to carbon storage and biodiversity. But can ranching really be green?

As Rocket Companies' CFO addresses Wall Street, the real story isn't just profits. It's the construction of a data-driven ecosystem designed to dominate homeownership.

As CEO William Brown prepares for a key investor conference, all eyes are on 3M's ability to balance its ambitious innovation goals with lingering legal battles.

DocGo's CEO heads to a major conference to sell its 'proactive healthcare revolution.' But can its vision overcome recent financial hurdles and a key pivot?

As Aramark executives prepare for Goldman Sachs, the real story isn't just financials. It's Nexus, a new division building the cities that power our AI future.

With Hepatitis C royalties declining, Enanta Pharmaceuticals faces investors this month to sell its vision: a future built on novel RSV and immunology drugs.

As Iron Mountain executives prepare for key tech conferences, they aren't just presenting financials; they're selling a new identity as a data infrastructure leader.

With a haul of design awards, AULUMU is using its futuristic aesthetic not just to sell accessories, but to build a fully integrated tech ecosystem for modern life.

Bank-led BNPL usage has surged over 70% this year. As the holidays loom, financial institutions are arming to compete with fintechs for customer loyalty.

As its CFO prepares for a key conference, Bio-Rad is navigating a major restructuring, activist pressure, and a divided market performance. What will he say?